Briggs W. Morrison
2019
In 2019, Briggs W. Morrison earned a total compensation of $1.6M as Chief Executive Officer at Syndax Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,375 |
|---|---|
| Option Awards | $763,574 |
| Salary | $583,055 |
| Other | $3,000 |
| Total | $1,612,004 |
Morrison received $763.6K in option awards, accounting for 47% of the total pay in 2019.
Morrison also received $262.4K in non-equity incentive plan, $583.1K in salary and $3K in other compensation.
Rankings
In 2019, Briggs W. Morrison's compensation ranked 6,979th out of 13,971 executives tracked by ExecPay. In other words, Morrison earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,979 out of 13,971 | 50th |
Division Manufacturing | 2,668 out of 5,695 | 53rd |
Major group Chemicals And Allied Products | 976 out of 2,194 | 56th |
Industry group Drugs | 825 out of 1,880 | 56th |
Industry Pharmaceutical Preparations | 606 out of 1,392 | 57th |
Source: SEC filing on April 29, 2020.
Morrison's colleagues
We found two more compensation records of executives who worked with Briggs W. Morrison at Syndax Pharmaceuticals in 2019.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019